Industry News
Biotechnology Industry News
AN2 upsizes IPO, teeing up bid to revitalize antibiotic let go by GSK and Pfizer
AN2 upsizes IPO, teeing up bid to revitalize antibiotic let go by GSK and Pfizer ntaylor Fri, 03/25/2022 - 07:50
MEI rocked as FDA request for randomized data on cancer drug ends hopes of accelerated approval
MEI rocked as FDA request for randomized data on cancer drug ends hopes of accelerated approval ntaylor Fri, 03/25/2022 - 05:26
Chutes & Ladders—After 9 years at Merck, Roy Baynes follows Roger Perlmutter to Eikon
Chutes & Ladders—After 9 years at Merck, Roy Baynes follows Roger Perlmutter to Eikon mbayer Thu, 03/24/2022 - 14:03
Ligand takes a crack at a SPAC to buoy spun-off antibody discovery business
Ligand takes a crack at a SPAC to buoy spun-off antibody discovery business mbayer Thu, 03/24/2022 - 11:12
Homology gets clarity on how to resolve pheNIX gene therapy hold
Homology gets clarity on how to resolve pheNIX gene therapy hold aarmstrong Thu, 03/24/2022 - 10:22
From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma
From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma mbayer Thu, 03/24/2022 - 09:29
Pfizer grabs another breakthrough tag for RSV shot in older adults
Pfizer grabs another breakthrough tag for RSV shot in older adults aarmstrong Thu, 03/24/2022 - 09:04
Hookipa CEO waives 50% of salary in bet on brighter days
Hookipa CEO waives 50% of salary in bet on brighter days ntaylor Thu, 03/24/2022 - 08:34
Orion staff brace for layoffs, program terminations after cancer and pain emerge as R&D stars
Orion staff brace for layoffs, program terminations after cancer and pain emerge as R&D stars ntaylor Thu, 03/24/2022 - 06:57
Could a simple dietary supplement treat Alzheimer’s?
Could a simple dietary supplement treat Alzheimer's? mbayer Wed, 03/23/2022 - 14:23
Celsius turns up the heat with lead drug selection, $83M financing
Celsius turns up the heat with lead drug selection, $83M financing ssorensen Wed, 03/23/2022 - 13:46
Another Eylea rival struggles in phase 2, this time fielded by Ribomic
Another Eylea rival struggles in phase 2, this time fielded by Ribomic aarmstrong Wed, 03/23/2022 - 12:40
How creative chemistry and collaboration synthesized a better drug strategy for Enterin
How creative chemistry and collaboration synthesized a better drug strategy for Enterin mwen Wed, 03/23/2022 - 10:49
After ‘masterful’ development of Keytruda, Merck’s CMO follows Roger Perlmutter to Eikon
After ‘masterful’ development of Keytruda, Merck’s CMO follows Roger Perlmutter to Eikon aarmstrong Wed, 03/23/2022 - 10:23
2seventy bio’s honeymoon phase is over as job cuts hit 6% of staff
2seventy bio's honeymoon phase is over as job cuts hit 6% of staff mbayer Wed, 03/23/2022 - 10:08
Former Pfizer staffers counter pharma giant’s ‘belated and ill-founded’ trade secrets case
Former Pfizer staffers counter pharma giant's ‘belated and ill-founded’ trade secrets case aarmstrong Wed, 03/23/2022 - 09:50
Pfizer’s $7B bet delivers phase 3 success, advancing bid to establish new drug in ulcerative colitis Arena
Pfizer's $7B bet delivers phase 3 success, advancing bid to establish new drug in ulcerative colitis Arena ntaylor Wed, 03/23/2022 - 08:30
Despite 0% response rate, 4D hits primary endpoint in Keytruda combo trial, sending stock skyward
Despite 0% response rate, 4D hits primary endpoint in Keytruda combo trial, sending stock skyward ntaylor Wed, 03/23/2022 - 07:08
LifeMine locks down $70M ‘dream scenario’ fungi partnership with GSK—and a fundraising, too
LifeMine locks down $70M 'dream scenario' fungi partnership with GSK—and a fundraising, too aarmstrong Tue, 03/22/2022 - 14:27
NIH-backed HDT Bio sues Indian partner for $950M, alleging it stole trade secrets
NIH-backed HDT Bio sues Indian partner for $950M, alleging it stole trade secrets mbayer Tue, 03/22/2022 - 13:28